Descovy’s approval for PrEP showcases real-life ramifications of leaving trans people out of research. But including trans people is about more than just saying trans people are welcome, says researcher Brian Minalga.
Jan. 23, 2020: Neurocognitive benefits of cannabis use; how unquantifiable HIV in CSF correlates to executive function; updated findings on efavirenz and microcephaly; cost-efficacy of a specialized HIV care coordination team.
“I’m not a physician. … We can diagnose and treat, but fundamentally we are taught to care.”
Reducing the time between contracting HIV and being diagnosed and starting treatment is key to ending the epidemic, this study finds.
Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work
Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.
Dec. 19, 2019: Often-insufficient CD4 and viral load testing for women; factors affecting syphilis incidence among women with HIV; STI testing rates among people with HIV; the effect of benzodiazepines on neurocognition.
The HIV services organization Housing Works implemented a hepatitis C treatment program in New York City, with very high completion rates.
One New York-based provider who works specifically with trans and gender non-conforming patients outlines what needs to change in the health care world to get Black trans women the care they deserve.
Common Antidepressant Reduces Meth Use and High-Risk Sexual Behavior for Gay and Bisexual Men and Transgender Women
Could this give hope to people struggling with crystal meth addiction?
Even after a series of reforms in 2015, advocates say U.S. policy still discriminates and furthers HIV stigma. Anthony Santella, Dr.P.H., M.P.H., has a better idea.